Page results
-
This information is for patients who are doing a breath test at home. It includes the risks, and explains how to prepare, complete and return the test, as well as what to expect after the test.
-
Our new report shows the difference charitable funds can make to patients, staff and research at UCLH
-
If your doctor has referred you for a blood test, please book your phlebotomy (blood test) appointment online in advance.
-
Information about activating your MyCare UCLH app.
-
Patient information leaflet for Functional Electrical Stimulation (FES) Clinic
-
Mr Patrick Grover is a neurosurgeon with a particular expertise in the management of tumours of the skull base such as vestibular schwannomas and meningiomas, as well as Cerebral Aneurysms, AVMs and cavernomas.
-
Mr Pat O'Brien has been a consultant at UCLH since 1999 and specialises in caring for women with medical problems in pregnancy and complicated births. His research interests are in the same areas.
-
Antenatal care and screening is an essential part of maternity care for all women. We provide state-of-the-art ultrasound screening, specialist obstetric and midwifery clinics.
-
This page is aimed at providing guidance and recommendations for patients, carers or family members following a high dose examination or procedure performed in the Neuroradiology department at NHNN, which involved ionising radiation.
-
Irreversible Electroporation for Prostate Cancer (IRE or Nanoknife™) patient information page.
File results
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment
-
FOI/2022/0540 - Electronic patient record
-
FOI/2022/0541 - Serious Incidents Level 2 deaths/ serious harm